We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-0.96%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$273M
AUM Growth
-$56.5M
(-17%)
Cap. Flow
-$54.5M
Cap. Flow
% of AUM
-20%
Top 10 Holdings %
Top 10 Hldgs %
37.85%
Holding
118
New
32
Increased
13
Reduced
18
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$9.34M |
| 2 |
AbbVie
ABBV
|
+$9.18M |
| 3 |
HOLX
Hologic
HOLX
|
+$8.27M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$7.93M |
| 5 |
iShares Europe ETF
IEV
|
+$7.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$9.7M |
| 2 |
Abbott
ABT
|
+$8.67M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$8.13M |
| 4 |
Eli Lilly
LLY
|
+$7.49M |
| 5 |
Novartis
NVS
|
+$7.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.58% |
| 2 | Industrials | 3.66% |
| 3 | Financials | 1.77% |
| 4 | Technology | 1.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Accuray
ARAY
$35.7M
| $1.37M | 0.5% |
298,793
-201,207
| -40% | -$1.04M |
|
|
IMMU
52
DELISTED
Immunomedics Inc
IMMU
| $1.24M | 0.45% |
336,500
+16,935
| +5% | +$50.1K |
|
|
AGRX
53
DELISTED
Agile Therapeutics
AGRX
| $938K | 0.34% |
82
+70
| +583% | +$981K |
|
|
VIVE
54
DELISTED
VIVEVE MED INC
VIVE
| $808K | 0.3% |
157
-156
| -50% | -$928K |
|
|
WMGIZ
55
DELISTED
Wright Medical Group, Inc. Contingent Value Right
WMGIZ
| $775K | 0.28% |
586,936
| – | – |
|
|
AMRN
56
Amarin Corp
AMRN
$297M
| $770K | 0.28% |
12,500
-11,250
| -47% | -$715K |
|
|
FPRX
57
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $709K | 0.26% |
14,150
-850
| -6% | -$44.7K |
|
58
Aldeyra Therapeutics
ALDX
$91.1M
| $669K | 0.25% |
125,000
+10,933
| +10% | +$64.1K |
|
|
XENT
59
CALL
DELISTED
Intersect ENT, Inc
XENT
| $645K | 0.24% |
+3,000
| New | +$38.8K |
|
|
OCRX
60
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $544K | 0.2% |
258,893
+9,931
| +4% | +$23.2K |
|
61
Apyx Medical
APYX
$134M
| $442K | 0.16% |
+123,000
| New | +$548K |
|
|
ADYX
62
DELISTED
Adynxx Inc
ADYX
| $344K | 0.13% |
9,717
| – | – |
|
|
NXTM
63
CALL
DELISTED
NxStage Medical Inc.
NXTM
| $278K | 0.1% |
10,600
-86,500
| -89% | -$2.14M |
|
64
Axogen
AXGN
$2.6B
| $222K | 0.08% |
+24,700
| New | +$213K |
|
|
STDY
65
DELISTED
SteadyMed Ltd
STDY
| $207K | 0.08% |
79,434
| – | – |
|
|
ELGX
66
PUT
DELISTED
Endologix Inc
ELGX
| $26K | 0.01% |
+460
| New | +$42.1K |
|
67
Ocugen
OCGN
$451M
| $23K | 0.01% |
225
-512
| -69% | -$71.1K |
|
|
68
CALL
Abbott
ABT
$190B
| – | – |
-87,700
| Closed | -$3.71M |
|
|
69
Abbott
ABT
$190B
| – | – |
-205,000
| Closed | -$8.67M |
|
70
Acadia Pharmaceuticals
ACAD
$5.07B
| – | – |
-123,066
| Closed | -$3.92M |
|
71
Alnylam Pharmaceuticals
ALNY
$29.3B
| – | – |
-61,625
| Closed | -$4.18M |
|
72
Amgen
AMGN
$224B
| – | – |
-43,460
| Closed | -$7.25M |
|
|
73
CALL
Accuray
ARAY
$35.7M
| – | – |
-100,000
| Closed | -$637K |
|
74
Centene
CNC
$32.5B
| – | – |
-212,958
| Closed | -$7.13M |
|
|
EXAS
75
CALL
DELISTED
Exact Sciences
EXAS
| – | – |
-100,000
| Closed | -$1.86M |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q4 2016 Portfolio in Review
As of Q4 2016, Pura Vida Investments held 118 positions worth $273M, down 17% from $329M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Pura Vida Investments withdrew a net $54.5M in Q4 2016, closing 50 positions and reducing 18 holdings. Its most notable exit was Stryker, an estimated $9.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 62% a quarter earlier, followed by Industrials and Financials.
Against the trend, Pura Vida Investments opened a new position in UnitedHealth worth $10M.
- Pura Vida Investments's largest Q4 2016 buy was UnitedHealth: 62,500 shares worth $10M.
- Pura Vida Investments added most to Athenahealth, Inc. in Q4 2016, an estimated $4.3M increase.
- Pura Vida Investments's biggest Q4 2016 reduction was Aetna Inc, cutting an estimated $3.63M.
- Pura Vida Investments fully exited Stryker in Q4 2016, selling an estimated $9.7M.
- Pura Vida Investments's ten largest holdings make up 38% of its $273M portfolio in Q4 2016.
- Pura Vida Investments opened 32 new positions and closed 50 in Q4 2016.
- Pura Vida Investments's portfolio value fell 17% quarter-over-quarter to $273M.
Based on Pura Vida Investments's 13F filing for Q4 2016, filed 14 Feb 2017.